Insurance - Life
Compare Stocks
5 / 10Stock Comparison
JXN vs BLK vs IVZ vs TROW vs APO
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Asset Management - Global
JXN vs BLK vs IVZ vs TROW vs APO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Life | Asset Management | Asset Management | Asset Management | Asset Management - Global |
| Market Cap | $7.68B | $165.65B | $11.92B | $22.54B | $73.67B |
| Revenue (TTM) | $5.86B | $20.41B | $6.38B | $7.31B | $30.30B |
| Net Income (TTM) | $-373M | $6.10B | $-243M | $2.09B | $4.48B |
| Gross Margin | 103.0% | 49.4% | 43.2% | 62.7% | 88.5% |
| Operating Margin | -8.5% | 37.1% | -10.9% | 29.9% | 34.4% |
| Forward P/E | 4.7x | 20.1x | 10.4x | 11.2x | 14.4x |
| Total Debt | $4.61B | $14.22B | $10.12B | $860M | $13.36B |
| Cash & Equiv. | $5.70B | $12.76B | $1.98B | $3.38B | $19.24B |
JXN vs BLK vs IVZ vs TROW vs APO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Jackson Financial I… (JXN) | 100 | 423.5 | +323.5% |
| BlackRock, Inc. (BLK) | 100 | 127.3 | +27.3% |
| Invesco Ltd. (IVZ) | 100 | 111.3 | +11.3% |
| T. Rowe Price Group… (TROW) | 100 | 52.7 | -47.3% |
| Apollo Global Manag… (APO) | 100 | 207.5 | +107.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JXN vs BLK vs IVZ vs TROW vs APO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JXN has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 116.1%, EPS growth -102.0%, 3Y rev CAGR -11.7%
- 116.1% revenue growth vs TROW's 3.1%
- Lower P/E (4.7x vs 11.2x)
BLK is the #2 pick in this set and the best alternative if quality and dividends is your priority.
- 31.2% margin vs JXN's -6.4%
- 1.9% yield, 15-year raise streak, vs TROW's 4.9%
IVZ is the clearest fit if your priority is momentum.
- +93.1% vs APO's +0.4%
TROW ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 1.18, yield 4.9%
- Lower volatility, beta 1.18, Low D/E 7.1%, current ratio 73.08x
- Beta 1.18, yield 4.9%, current ratio 73.08x
- NIM 3.4% vs BLK's 0.2%
APO is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 7.6% 10Y total return vs JXN's 288.5%
- PEG 0.19 vs BLK's 2.47
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 116.1% revenue growth vs TROW's 3.1% | |
| Value | Lower P/E (4.7x vs 11.2x) | |
| Quality / Margins | 31.2% margin vs JXN's -6.4% | |
| Stability / Safety | Beta 1.18 vs IVZ's 1.67, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs TROW's 4.9% | |
| Momentum (1Y) | +93.1% vs APO's +0.4% | |
| Efficiency (ROA) | 14.4% ROA vs IVZ's -0.9%, ROIC 13.3% vs -2.3% |
JXN vs BLK vs IVZ vs TROW vs APO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
JXN vs BLK vs IVZ vs TROW vs APO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JXN leads in 2 of 6 categories
TROW leads 1 • BLK leads 0 • IVZ leads 0 • APO leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — JXN and BLK each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
APO is the larger business by revenue, generating $30.3B annually — 5.2x JXN's $5.9B. BLK is the more profitable business, keeping 31.2% of every revenue dollar as net income compared to JXN's -6.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5.9B | $20.4B | $6.4B | $7.3B | $30.3B |
| EBITDAEarnings before interest/tax | -$422M | $8.3B | $1.2B | $2.7B | $11.5B |
| Net IncomeAfter-tax profit | -$373M | $6.1B | -$243M | $2.1B | $4.5B |
| Free Cash FlowCash after capex | $4.2B | $3.9B | $1.9B | $2.3B | $5.4B |
| Gross MarginGross profit ÷ Revenue | +103.0% | +49.4% | +43.2% | +62.7% | +88.5% |
| Operating MarginEBIT ÷ Revenue | -8.5% | +37.1% | -10.9% | +29.9% | +34.4% |
| Net MarginNet income ÷ Revenue | -6.4% | +31.2% | -4.4% | +28.5% | +14.8% |
| FCF MarginFCF ÷ Revenue | +71.0% | +23.0% | +22.6% | +20.2% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -22.1% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -12.0% | -22.7% | +34.2% | +3.7% | +16.3% |
Valuation Metrics
JXN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 11.2x trailing earnings, TROW trades at a 56% valuation discount to BLK's 25.4x P/E. Adjusting for growth (PEG ratio), APO offers better value at 0.23x vs BLK's 3.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.7B | $165.7B | $11.9B | $22.5B | $73.7B |
| Enterprise ValueMkt cap + debt − cash | $6.6B | $167.1B | $20.1B | $20.0B | $67.8B |
| Trailing P/EPrice ÷ TTM EPS | -458.79x | 25.42x | -16.77x | 11.20x | 17.60x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.67x | 20.10x | 10.44x | 11.22x | 14.42x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.13x | — | — | 0.23x |
| EV / EBITDAEnterprise value multiple | — | 20.62x | 16.34x | 7.64x | 5.92x |
| Price / SalesMarket cap ÷ Revenue | 1.15x | 8.12x | 1.87x | 3.08x | 2.43x |
| Price / BookPrice ÷ Book value/share | 0.75x | 3.28x | 0.94x | 1.92x | 1.83x |
| Price / FCFMarket cap ÷ FCF | 1.33x | 35.24x | 8.27x | 15.24x | 9.89x |
Profitability & Efficiency
TROW leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
TROW delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-4 for JXN. TROW carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), JXN scores 7/9 vs APO's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.6% | +9.9% | -1.7% | +17.6% | +12.1% |
| ROA (TTM)Return on assets | -0.1% | +3.7% | -0.9% | +14.4% | +1.0% |
| ROICReturn on invested capital | -0.9% | +9.9% | -2.3% | +13.3% | +16.0% |
| ROCEReturn on capital employed | -0.0% | +5.8% | -2.6% | +15.9% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 6 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.45x | 0.29x | 0.78x | 0.07x | 0.31x |
| Net DebtTotal debt minus cash | -$1.1B | $1.5B | $8.1B | -$2.5B | -$5.9B |
| Cash & Equiv.Liquid assets | $5.7B | $12.8B | $2.0B | $3.4B | $19.2B |
| Total DebtShort + long-term debt | $4.6B | $14.2B | $10.1B | $860M | $13.4B |
| Interest CoverageEBIT ÷ Interest expense | -4.22x | 9.27x | -6.19x | — | 28.98x |
Total Returns (Dividends Reinvested)
JXN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JXN five years ago would be worth $38,852 today (with dividends reinvested), compared to $6,915 for TROW. Over the past 12 months, IVZ leads with a +93.1% total return vs APO's +0.4%. The 3-year compound annual growth rate (CAGR) favors JXN at 49.8% vs TROW's 3.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.3% | -1.1% | +0.4% | +0.2% | -12.5% |
| 1-Year ReturnPast 12 months | +36.5% | +18.3% | +93.1% | +18.9% | +0.4% |
| 3-Year ReturnCumulative with dividends | +236.0% | +75.7% | +79.8% | +11.5% | +115.8% |
| 5-Year ReturnCumulative with dividends | +288.5% | +33.5% | +8.2% | -30.9% | +135.1% |
| 10-Year ReturnCumulative with dividends | +288.5% | +245.8% | +22.1% | +93.6% | +759.2% |
| CAGR (3Y)Annualised 3-year return | +49.8% | +20.7% | +21.6% | +3.7% | +29.2% |
Risk & Volatility
Evenly matched — IVZ and TROW each lead in 1 of 2 comparable metrics.
Risk & Volatility
TROW is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IVZ currently trades 90.6% from its 52-week high vs APO's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.31x | 1.28x | 1.67x | 1.18x | 1.43x |
| 52-Week HighHighest price in past year | $123.61 | $1219.94 | $29.61 | $118.22 | $157.28 |
| 52-Week LowLowest price in past year | $78.76 | $914.84 | $14.10 | $85.51 | $99.56 |
| % of 52W HighCurrent price vs 52-week peak | +89.1% | +87.5% | +90.6% | +87.6% | +81.3% |
| RSI (14)Momentum oscillator 0–100 | 58.0 | 61.3 | 69.4 | 78.2 | 64.9 |
| Avg Volume (50D)Average daily shares traded | 540K | 790K | 5.1M | 2.3M | 5.2M |
Analyst Outlook
Evenly matched — BLK and TROW each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JXN as "Hold", BLK as "Buy", IVZ as "Hold", TROW as "Hold", APO as "Buy". Consensus price targets imply 23.1% upside for APO (target: $157) vs -2.3% for TROW (target: $101). For income investors, TROW offers the higher dividend yield at 4.93% vs APO's 1.67%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $120.00 | $1311.78 | $29.72 | $101.20 | $157.25 |
| # AnalystsCovering analysts | 6 | 33 | 28 | 38 | 28 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | +1.9% | +3.1% | +4.9% | +1.7% |
| Dividend StreakConsecutive years of raises | 4 | 15 | 4 | 3 | 3 |
| Dividend / ShareAnnual DPS | $3.17 | $20.46 | $0.83 | $5.11 | $2.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.7% | +1.2% | +15.6% | +2.8% | +1.0% |
JXN leads in 2 of 6 categories (Valuation Metrics, Total Returns). TROW leads in 1 (Profitability & Efficiency). 3 tied.
JXN vs BLK vs IVZ vs TROW vs APO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JXN or BLK or IVZ or TROW or APO a better buy right now?
For growth investors, Jackson Financial Inc.
(JXN) is the stronger pick with 116. 1% revenue growth year-over-year, versus 3. 1% for T. Rowe Price Group, Inc. (TROW). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 2x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JXN or BLK or IVZ or TROW or APO?
On trailing P/E, T.
Rowe Price Group, Inc. (TROW) is the cheapest at 11. 2x versus BlackRock, Inc. at 25. 4x. On forward P/E, Jackson Financial Inc. is actually cheaper at 4. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apollo Global Management, Inc. wins at 0. 19x versus BlackRock, Inc. 's 2. 47x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — JXN or BLK or IVZ or TROW or APO?
Over the past 5 years, Jackson Financial Inc.
(JXN) delivered a total return of +288. 5%, compared to -30. 9% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: APO returned +759. 2% versus IVZ's +22. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JXN or BLK or IVZ or TROW or APO?
By beta (market sensitivity over 5 years), T.
Rowe Price Group, Inc. (TROW) is the lower-risk stock at 1. 18β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 42% more volatile than TROW relative to the S&P 500. On balance sheet safety, T. Rowe Price Group, Inc. (TROW) carries a lower debt/equity ratio of 7% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — JXN or BLK or IVZ or TROW or APO?
By revenue growth (latest reported year), Jackson Financial Inc.
(JXN) is pulling ahead at 116. 1% versus 3. 1% for T. Rowe Price Group, Inc. (TROW). On earnings-per-share growth, the picture is similar: BlackRock, Inc. grew EPS 15. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JXN or BLK or IVZ or TROW or APO?
BlackRock, Inc.
(BLK) is the more profitable company, earning 31. 2% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 31. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLK leads at 37. 1% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — APO leads at 88. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JXN or BLK or IVZ or TROW or APO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apollo Global Management, Inc. (APO) is the more undervalued stock at a PEG of 0. 19x versus BlackRock, Inc. 's 2. 47x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Jackson Financial Inc. (JXN) trades at 4. 7x forward P/E versus 20. 1x for BlackRock, Inc. — 15. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for APO: 23. 1% to $157. 25.
08Which pays a better dividend — JXN or BLK or IVZ or TROW or APO?
All stocks in this comparison pay dividends.
T. Rowe Price Group, Inc. (TROW) offers the highest yield at 4. 9%, versus 1. 7% for Apollo Global Management, Inc. (APO).
09Is JXN or BLK or IVZ or TROW or APO better for a retirement portfolio?
For long-horizon retirement investors, Apollo Global Management, Inc.
(APO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 7% yield, +759. 2% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (APO: +759. 2%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JXN and BLK and IVZ and TROW and APO?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: JXN is a small-cap high-growth stock; BLK is a mid-cap quality compounder stock; IVZ is a mid-cap income-oriented stock; TROW is a mid-cap deep-value stock; APO is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.